Business / Finance

RSS

ST Asia signs licensing deal with PharmaMar to distribute new multiple myeloma drug in South East Asia

International biopharmaceutical company Specialised Therapeutics Asia will supply and distribute a novel oncology drug candidate throughout South East Asia, following an exclusive licensing deal with European pharmaceutical company PharmaMar.

3 Feb 2016

Hillenbrand acquires Red Valve for $131.9 million

Hillenbrand, Inc. has completed its previously announced acquisition of Red Valve Company, Inc. for a purchase price of $131.9 million in cash, including $3.3 million for related real estate.

2 Feb 2016

Aflac's total revenues decrease 3.5% to $5.3 billion in fourth quarter 2015

Aflac Incorporated today reported its fourth quarter results. Reflecting the weaker yen/dollar exchange rate, total revenues decreased 3.5% to $5.3 billion during the fourth quarter of 2015, compared with $5.5 billion in the fourth quarter of 2014. Net earnings were $730 million, or $1.71 per diluted share, compared with $703 million, or $1.57 per share, a year ago.

1 Feb 2016

FedMed gains access to Trovagene's Precision Cancer Monitoring tests and service

Trovagene, Inc., a developer of cell-free molecular diagnostics, announced today that it has entered into an agreement with FedMed, Inc. establishing health benefit access to Trovagene's full line of Precision Cancer Monitoring (PCM) tests and services.

1 Feb 2016

HUYA, Eisai sign exclusive license agreement for HBI-8000 in Japan and other Asian countries

HUYA Bioscience International President, CEO, Executive Chairman & Founder Dr. Mireille Gillings announced that Eisai Co., Ltd. has acquired from HUYA an exclusive license agreement for HBI-8000 in Japan, South Korea, Thailand, Malaysia, Indonesia, Philippines, Vietnam and Singapore.

1 Feb 2016

Allergan and AstraZeneca partner to develop, commercialize ATM-AVI for MBL-producing pathogens

Allergan plc today announced that it has entered into a global agreement with AstraZeneca to develop and commercialize ATM-AVI, an investigational, fixed-dose antibiotic combining aztreonam and avibactam.

30 Jan 2016

Refugee women have higher risk of giving birth too early than non-refugee immigrants

Refugee women who come to Canada have greater risk of giving birth prematurely than non-refugee immigrants, a study by a St. Michael's Hospital researcher has found. Those risks are fueled by the fact that the preterm birth rate was 7.1 per cent among secondary refugees - those who spent more than six months in a transit country before arriving in Canada -compared to five per cent among secondary, non-refugee immigrants.

29 Jan 2016

CosmosID announces $6M in Series B funding round

CosmosID, the leading genomic big data company focused on microbiome research, outbreak investigations, and infectious disease diagnostics, using next-generation DNA sequencing, announced $6M in Series B funding.

28 Jan 2016

SCIO Health Analytics announces acquisition of Clear Vision Information Systems

SCIO Health Analytics today announced it has acquired Clear Vision Information Systems of Westlake Village, California, creators of an analytics solution and services suite that provides risk adjustment and quality metric strategies for health plans and providers.

27 Jan 2016

Halozyme closes $150 million royalty-backed debt transaction

Halozyme Therapeutics, Inc. today announced that it has closed the previously announced $150 million royalty-backed debt transaction with investment funds managed by Pharmakon Advisors and Athyrium Capital Management. The debt is secured by future royalties of ENHANZE products, received only from Halozyme's collaborations with Roche and Baxalta.

27 Jan 2016

Prime Healthcare Services closes $700 million senior secured credit facility

Prime Healthcare Services, Inc. today announced that it has closed a $700 million senior secured credit facility ("Facility") lead jointly by Wells Fargo Bank, N.A. and Barclays Bank, PLC.

26 Jan 2016

Perrigo closes previously announced acquisition of generic Retin-A portfolio from Matawan Pharmaceuticals

Perrigo Company plc announced today that it has completed the previously announced acquisition of a portfolio of generic dosage forms and strengths of Retin-A (tretinoin) from Matawan Pharmaceuticals, LLC.

25 Jan 2016

Remaining Pentax Italia shares acquired by Pentax GmbH

PENTAX Europe GmbH has acquired the remaining stock of PENTAX Italia S.r.L. from Movi S.p.A. This further investment by PENTAX Europe GmbH into the Italian healthcare market strengthens PENTAX Medical’s position in Italy and will bring enhanced customer and professional education services to its Italian customers.

From PENTAX Medical Company 22 Jan 2016

Abingworth announces closing of $105m clinical co-development fund

Abingworth, the international investment group dedicated to life sciences, today announced the closing of the $105m Abingworth Clinical Co-Development Fund (ACCF), its 11th life sciences fund. ACCF was oversubscribed, exceeding its target of $100 million, and will co-invest with other Abingworth funds.

21 Jan 2016

Eldermark obtains exclusive license to market eMenuCHOICE to senior living and skilled nursing settings

Most adults are accustomed to choosing what they want to eat at each meal. However, when they enter a senior housing or skilled nursing facility, the option to make food choices has traditionally gone away. On the operations side, rising food costs place stress on already tight budgets.

21 Jan 2016

MedNet Solutions attains record-setting corporate growth in 2015

MedNet Solutions, an innovative SaaS-based eClinical technology company that supports the entire spectrum of clinical research, is pleased to announce the attainment of record-setting corporate growth in 2015.

20 Jan 2016

Upsher-Smith, Saniona sign drug discovery and development agreement

Upsher-Smith Laboratories, Inc., through its wholly-owned subsidiary Proximagen Ltd., and Saniona, a leading biotech company in the field of ion channels, today announce that they have entered into a drug discovery and development collaboration.

20 Jan 2016

CASI Pharmaceuticals receives $10.3 million in strategic financing

CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to innovative therapeutics addressing cancer and other unmet medical needs, announces it has received approximately $10.3 million in a strategic financing previously announced on September 21, 2015.

19 Jan 2016

Professor Graham Boulnois appointed as chairman of Medicines Technologies Catapult

Life sciences businessman and academic Professor Graham Boulnois has been appointed as chairman of the Medicines Technologies Catapult, one of the latest technology and innovation centres set to open this year.

19 Jan 2016

Sentry Data Systems announces acquisition of Agilum Healthcare Intelligence

Today, Sentry Data Systems, Inc. announced its acquisition of Nashville-based Agilum Healthcare Intelligence. Sentry, the 2014 KLAS Category Leader for 340B Management Solutions, is a provider of SaaS-based technology and data analytics solutions that help healthcare organizations manage costs, compliance and outcomes.

18 Jan 2016

Business / Finance

ST Asia signs licensing deal with PharmaMar to distribute new multiple myeloma drug in South East Asia

Hillenbrand acquires Red Valve for $131.9 million

Aflac's total revenues decrease 3.5% to $5.3 billion in fourth quarter 2015

FedMed gains access to Trovagene's Precision Cancer Monitoring tests and service

HUYA, Eisai sign exclusive license agreement for HBI-8000 in Japan and other Asian countries

Allergan and AstraZeneca partner to develop, commercialize ATM-AVI for MBL-producing pathogens

Refugee women have higher risk of giving birth too early than non-refugee immigrants

CosmosID announces $6M in Series B funding round

SCIO Health Analytics announces acquisition of Clear Vision Information Systems

Halozyme closes $150 million royalty-backed debt transaction

Prime Healthcare Services closes $700 million senior secured credit facility

Perrigo closes previously announced acquisition of generic Retin-A portfolio from Matawan Pharmaceuticals

Remaining Pentax Italia shares acquired by Pentax GmbH

Abingworth announces closing of $105m clinical co-development fund

Eldermark obtains exclusive license to market eMenuCHOICE to senior living and skilled nursing settings

MedNet Solutions attains record-setting corporate growth in 2015

Upsher-Smith, Saniona sign drug discovery and development agreement

CASI Pharmaceuticals receives $10.3 million in strategic financing

Professor Graham Boulnois appointed as chairman of Medicines Technologies Catapult

Sentry Data Systems announces acquisition of Agilum Healthcare Intelligence

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Latest News